BASOPHIL PERCENTAGE DECREASED side effect
What is BASOPHIL PERCENTAGE DECREASED ?BASOPHIL PERCENTAGE DECREASED : Permax Side Effects Report #5671659-6
Physician from JAPAN reported PERMAX problem on Mar 05, 2008. Female patient, 81 years of age, was diagnosed with parkinson's disease and was treated with PERMAX. After drug was administered, patient experienced the following problems/side effects: basophil percentage decreased, eosinophilic pneumonia acute, interstitial lung disease, lymphocyte percentage decreased, lymphocyte stimulation test positive, monocyte percentage decreased, neutrophil percentage decreased, pleural calcification, pleural effusion, . PERMAX dosage: unknown. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, AMANTADINE, CLONAZEPAM, LEVODOPA BENSERAZIDE HYDROCHLO, LEVODOPA BENSERAZIDE HYDROCHLO. Patient was hospitalized. Patient recovered.
BASOPHIL PERCENTAGE DECREASED : Risedronate Side Effects Report #5400554-2
RISEDRONATE problem was reported by a Physician from JAPAN on July 09, 2007. Female patient, 67 years of age, was diagnosed with osteoporosis, hypertension, hyperlipidaemia, gastritis and was treated with RISEDRONATE. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, basophil percentage decreased, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, monocyte percentage increased, red blood cell count decreased, . RISEDRONATE dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BLOPRESS, LIPITOR, STOGAR, ALFAROL. Patient was hospitalized. Patient recovered.
BASOPHIL PERCENTAGE DECREASED : Risedronate Side Effects Report #5400554-2
Physician from JAPAN reported RISEDRONATE problem on July 09, 2007. Female patient, 67 years of age, was diagnosed with osteoporosis, hypertension, hyperlipidaemia, gastritis and was treated with RISEDRONATE. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, basophil percentage decreased, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, monocyte percentage increased, red blood cell count decreased, . RISEDRONATE dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BLOPRESS, LIPITOR, STOGAR, ALFAROL. Patient was hospitalized. Patient recovered.